Drug research ReNeuron Group Focuses on Exosome Technology Validation and Seeks New Investors Simon Rowe Aug 5, 2024 ReNeuron Group PLC (AIM:RENE, OTC:RNUGF), a stem cell-derived exosome-based drug delivery platform developer, is…
